Skip to main content
Premium Trial:

Request an Annual Quote

Microarrayer Shop Aushon BioSystems Closes $7.8M in Series A Financing

NEW YORK (GenomeWeb News) — Microarrayer developer Aushon BioSystems has raised $7.8 million in a Series A financing round, the company said today.
 
Financing company North Bridge Venture Partners led the round, which ended on Oct. 12, Aushon said.
 
The early stage company, based in Burlington, Mass., makes microarrayers for protein, antibody, and cell research. Its clients include the National Institutes of Health, M.D. Anderson Cancer Center, and George Mason University.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.